Positron Emission Tomography in Determining Stage of Esophageal Cancer
Study Information
Alliance Study ID: ACOSOG-Z0060
NCT Study ID (ClinicalTrials.gov): NCT00004867
Disease or Cancer Type: Gastrointestinal Cancers – Pancreatic / Gastric / Esophageal / Liver / Biliary
Alliance Study Chair: Bryan F. Meyers, MD, MPH
Status: COMPLETED
Study Description
RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer.
PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information